Evron E - Search Results

1

Loss of cyclin D2 expression in the majority of breast cancers is associated with promoter hypermethylation.

Evron E, Umbricht CB, Korz D, Raman V, Loeb DM, Niranjan B, Buluwela L, Weitzman SA, Marks J, Sukumar S. Evron E, et al. Cancer Res. 2001 Mar 15;61(6):2782-7. Cancer Res. 2001. PMID: 11289162

2

Loss of the tight junction protein claudin-7 correlates with histological grade in both ductal carcinoma in situ and invasive ductal carcinoma of the breast.

Kominsky SL, Argani P, Korz D, Evron E, Raman V, Garrett E, Rein A, Sauter G, Kallioniemi OP, Sukumar S. Kominsky SL, et al. Among authors: evron e. Oncogene. 2003 Apr 3;22(13):2021-33. doi: 10.1038/sj.onc.1206199. Oncogene. 2003. PMID: 12673207

3

Wilms' tumor suppressor gene (WT1) is expressed in primary breast tumors despite tumor-specific promoter methylation.

Loeb DM, Evron E, Patel CB, Sharma PM, Niranjan B, Buluwela L, Weitzman SA, Korz D, Sukumar S. Loeb DM, et al. Among authors: evron e. Cancer Res. 2001 Feb 1;61(3):921-5. Cancer Res. 2001. PMID: 11221883

4

Detection of breast cancer cells in ductal lavage fluid by methylation-specific PCR.

Evron E, Dooley WC, Umbricht CB, Rosenthal D, Sacchi N, Gabrielson E, Soito AB, Hung DT, Ljung B, Davidson NE, Sukumar S. Evron E, et al. Lancet. 2001 Apr 28;357(9265):1335-6. doi: 10.1016/s0140-6736(00)04501-3. Lancet. 2001. PMID: 11343741

5

Hypermethylation of 14-3-3 sigma (stratifin) is an early event in breast cancer.

Umbricht CB, Evron E, Gabrielson E, Ferguson A, Marks J, Sukumar S. Umbricht CB, et al. Among authors: evron e. Oncogene. 2001 Jun 7;20(26):3348-53. doi: 10.1038/sj.onc.1204438. Oncogene. 2001. PMID: 11423985

6

CpG methylation as a basis for breast tumor-specific loss of NES1/kallikrein 10 expression.

Li B, Goyal J, Dhar S, Dimri G, Evron E, Sukumar S, Wazer DE, Band V. Li B, et al. Among authors: evron e. Cancer Res. 2001 Nov 1;61(21):8014-21. Cancer Res. 2001. PMID: 11691827

7

High frequency of hypermethylation at the 14-3-3 sigma locus leads to gene silencing in breast cancer.

Ferguson AT, Evron E, Umbricht CB, Pandita TK, Chan TA, Hermeking H, Marks JR, Lambers AR, Futreal PA, Stampfer MR, Sukumar S. Ferguson AT, et al. Among authors: evron e. Proc Natl Acad Sci U S A. 2000 May 23;97(11):6049-54. doi: 10.1073/pnas.100566997. Proc Natl Acad Sci U S A. 2000. PMID: 10811911 Free PMC article.

8

Compromised HOXA5 function can limit p53 expression in human breast tumours.

Raman V, Martensen SA, Reisman D, Evron E, Odenwald WF, Jaffee E, Marks J, Sukumar S. Raman V, et al. Among authors: evron e. Nature. 2000 Jun 22;405(6789):974-8. doi: 10.1038/35016125. Nature. 2000. PMID: 10879542

9

DNA methylation of RASSF1A, HIN-1, RAR-beta, Cyclin D2 and Twist in in situ and invasive lobular breast carcinoma.

Fackler MJ, McVeigh M, Evron E, Garrett E, Mehrotra J, Polyak K, Sukumar S, Argani P. Fackler MJ, et al. Among authors: evron e. Int J Cancer. 2003 Dec 20;107(6):970-5. doi: 10.1002/ijc.11508. Int J Cancer. 2003. PMID: 14601057

10

Tissue specific DNA methylation in normal human breast epithelium and in breast cancer.

Avraham A, Cho SS, Uhlmann R, Polak ML, Sandbank J, Karni T, Pappo I, Halperin R, Vaknin Z, Sella A, Sukumar S, Evron E. Avraham A, et al. Among authors: evron e. PLoS One. 2014 Mar 20;9(3):e91805. doi: 10.1371/journal.pone.0091805. eCollection 2014. PLoS One. 2014. PMID: 24651077 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

69 results

Search Page

Filters